Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection

References

• Levkovitch-Verbin H, Spierer O, Vander S, Dardik R. Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline. Graefes Arch Clin Exp Ophthalmol 2011;249(6):849–57.
   PubMed Web of Science ®Google Scholar
• Baptiste DC, Hartwick AT, Jollimore CA, An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol Pharmacol 2004;66(5):1113–22.
   PubMed Web of Science ®Google Scholar
• Baptiste DC, Powell KJ, Jollimore CA, Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 2005;134(2):575–82.
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H, Kalev-Landoy M, Habot-Wilner Z, Melamed S. Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol 2006;124(4):520–6.
   PubMedGoogle Scholar
• Bosco A, Inman DM, Steele MR, Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008;49(4):1437–46.
   PubMed Web of Science ®Google Scholar
• Baptiste DC, Hartwick AT, Jollimore CA, An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol Pharmacol 2004;66:1113–22.
   PubMed Web of Science ®Google Scholar
• Hughes EH, Schlichtenbrede FC, Murphy CC, Minocycline delays photoreceptor death in the rds mouse through a microglia-independent mechanism. Exp Eye Res 2004;78(6):1077–84.
   PubMed Web of Science ®Google Scholar
• Zhang C, Lei B, Lam TT, Neuroprotection of photoreceptors by minocycline in light-induced retinal degeneration. Invest Ophthalmol Vis Sci 2004;45(8):2753–9.
   PubMed Web of Science ®Google Scholar
• Aronson AL. Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 1980;176(10 Spec No):1061–8.
   PubMed Web of Science ®Google Scholar
• Teng YD, Choi H, Onario RC, Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 2004;101(9):3071–6.
   PubMed Web of Science ®Google Scholar
• Kim HS, Suh YH. Minocycline and neurodegenerative diseases. Behav Brain Res 2009;196(2):168–79.
   PubMed Web of Science ®Google Scholar
• Yang LP, Zhu XA, Tso MO. Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Mol Vis 2007;13:1083–93.
   PubMed Web of Science ®Google Scholar
• Yrjanheikki J, Tikka T, Keinanen R, A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999;96(23):13496–500.
   PubMed Web of Science ®Google Scholar
• Garrido-Mesa N, Zarzuelo A, Galvez J. What is behind the non-antibiotic properties of minocycline? Pharmacol Res. 2013;67(1):18–30.
   PubMed Web of Science ®Google Scholar
• Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48(6):1393–9; discussion 9–401.
   PubMed Web of Science ®Google Scholar
• Zhu S, Stavrovskaya IG, Drozda M, Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002;417(6884):74–8.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu S, Drozda M, Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 2003;100(18):10483–7.
   PubMed Web of Science ®Google Scholar
• Chen M, Ona VO, Li M, Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000;6(7):797–801.
   PubMed Web of Science ®Google Scholar
• Wang J, Wei Q, Wang CY, Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004;279(19):19948–54.
   PubMed Web of Science ®Google Scholar
• Castanares M, Vera Y, Erkkila K, Minocycline up-regulates BCL-2 levels in mitochondria and attenuates male germ cell apoptosis. Biochem Biophys Res Commun 2005;337(2):663–9.
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H, Dardik R, Vander S, Melamed S. Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Exp Eye Res 2009;91(2):127–34.
   PubMed Web of Science ®Google Scholar
• Nickells RW, Semaan SJ, Schlamp CL. Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog Brain Res 2008;173:423–35.
   Google Scholar
• Qin Q, Patil K, Sharma SC. The role of Bax-inhibiting peptide in retinal ganglion cell apoptosis after optic nerve transection. Neurosci Lett 2004;372(1–2):17–21.
   PubMed Web of Science ®Google Scholar
• Chierzi S, Strettoi E, Cenni MC, Maffei L. Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J Neurosci 1999;19(19):8367–76.
   PubMed Web of Science ®Google Scholar
• Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994;25(4):431–8.
   PubMedGoogle Scholar
• Levkovitch-Verbin H, Dardik R, Vander S, Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci 2006;47(6):2491–7.
   PubMed Web of Science ®Google Scholar
• Kernt M, Neubauer AS, Eibl KH, Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2. Clin Ophthalmol 2010;4:591–604.
   PubMedGoogle Scholar